Xenon Pharmaceuticals Inc (XENE) - Kapitalizatsiyaning foydaga nisbati

Xenon Corp - XENE emitenti grafik logotipi

Xenon Pharmaceuticals (XENE) hozirda klinik sinovlarning yakuniy bosqichlarida bo'lib, bu savdolarning yo'qligi va R&D xarajatlarining ortishi operatsion richagni salbiy hududda saqlab turganini anglatadi. GURU.Markets grafigidagi P/E koeffitsiyenti tendentsiyasi, ushbu ko'rsatkich -9.20 qiymatida mustahkamlandi, joriy bosqichni tasdiqlaydi. Xenon Pharmaceuticals (XENE) epilepsiyaga qarshi kurashish uchun noyob kanal modulyatorlarini ishlab chiqmoqda, shu bilan birga ishlab chiqarish va logistikani uchinchi tomon pudratchilariga topshirmoqda.

Xenon Pharmaceuticals Inc - XENE Narxning foydaga nisbati (davr: 04.07.2022 - 16.11.2026)

Xenon Pharmaceuticals (XENE) kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning har tomonlama tahlili:Xenon (XENE)
Xenon Corp tovar namunasi

P/E koeffitsiyenti biznesning bozor qiymatini uning sof foydasiga nisbatan aks ettiradi va joriy rentabellik nuqtai nazaridan investitsiyalarning qoplanish muddatini baholash imkonini beradi. Kompaniyaning maqsadli P/E koeffitsiyentini tahlil qilish orqali investor bozor kutuvlarini Xenon Pharmaceuticals (XENE) fundamental qiymati bilan solishtiradi, bunda yuqori baholash epilepsiya dori vositalarini ishlab chiqishga akademik yondashuv va klinik bosqichlardan muvaffaqiyatli o'tish bilan asoslanadi.

Muhim raqobatchilar

Narxning foydaga nisbati BIIB|P/E multiplikatori NBIX|Regencell (RGC) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati axsome.com AXSM|P/E multiplikatori ACADIA Pharmaceuticals ACAD|Viking Therapeutics Inc - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Narxning foydaga nisbati|DNLI (Denali Therapeutics Inc) - Narxning foydaga nisbati|Narxning foydaga nisbati Harmony Biosciences Holdings, Inc.|Narxning foydaga nisbati BHVN|Narx-foyda koeffitsiyenti AMLX (Amylyx Pharmaceuticals, Inc.)|Bozor narxining sof foydaga nisbati TRVI|Narxning foydaga nisbati Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Narxning foydaga nisbati|CBLL: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PRTA (prothena.com)|Alector, Inc. (ALEC) - Narxning foydaga nisbati|Narx-foyda multiplikatori ANNX|Narxning foydaga nisbati Omeros Corp.|Neurogene Therapeutics (NGNE) - Biznesning o‘zini qoplash muddati|P/E multiplikatori ACIU|VYGR (Voyager Therapeutics) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NMRA (neumoratx.com)|SCLX: Narx-foyda multiplikatori|TVGN - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Alpha Cognition Inc.|CGTX: P/E multiplikatori|inhibikase.com (IKT) - P/E multiplikatori|Narxning foydaga nisbati Cassava Sciences Inc|ASRT - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Coya (COYA)|P/E multiplikatori VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - P/E multiplikatori|Biznesning o‘zini qoplash muddati alteritytherapeutics.com ATHE|CLNN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati PepGen Corp (PEPG)|Narxning foydaga nisbati Jupiter Neurosciences, Inc.|RLMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ANVS|Narx-foyda koeffitsiyenti Grace Tx GRCE|Narxning foydaga nisbati Firefly Neuroscience, Inc AIFF|KLTO: Narx-foyda multiplikatori|NRSN - Narxning foydaga nisbati|RVPH: Narxning foydaga nisbati|MTVA (MetaVia Inc.) - Narx-foyda koeffitsiyenti|NeurAxis Inc. (NRXS) - P/E multiplikatori|Narxning foydaga nisbati Helius Medical|Passage Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti NEUP (Neuphoria)|NERV - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ATHA (athira.com)|P/E multiplikatori Addex Therapeutics Ltd ADXN|Alzamend Neuro, Inc. - P/E multiplikatori|CYCN - P/E multiplikatori|PTIX (Protagenic Therapeutics, Inc.) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Pasithea (KTTA)|Narxning foydaga nisbati Cortigent|Kapitalizatsiyaning foydaga nisbati Avenue Therapeutics Inc. ATXI|Narxning foydaga nisbati brainstorm-cell.com (BCLI)|Narx-foyda koeffitsiyenti Cara Therapeutics, Inc CARA|P/E multiplikatori CHRO (chromocell.com)|Kompaniya qiymatining sof foydaga nisbati ELYM|Intra-Cellular Therapies Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Narxning foydaga nisbati|NKGN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati NeuroBo Pharmaceuticals|SAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SNPX|Trevena Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical, Inc. - Narxning foydaga nisbati|Cerevel Therapeutics - P/E multiplikatori